158 related articles for article (PubMed ID: 30877214)
1. Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis.
Malochet-Guinamand S; Lambert C; Gossec L; Soubrier M; Dougados M
J Rheumatol; 2020 Jan; 47(1):6-14. PubMed ID: 30877214
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
[TBL] [Abstract][Full Text] [Related]
3. Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
Lee JH; Cho SK; Han M; Kim D; Bae SC; Sung YK
Korean J Intern Med; 2014 Jul; 29(4):509-15. PubMed ID: 25045299
[TBL] [Abstract][Full Text] [Related]
4. [Post hip fracture care].
Tandjung R; Rosemann T
Praxis (Bern 1994); 2011 Jul; 100(15):917-21. PubMed ID: 21792807
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
[TBL] [Abstract][Full Text] [Related]
6. Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study.
Kawabata A; Yoshii T; Hirai T; Ushio S; Kaito T; Yamashita T; Fujiwara H; Nagamoto Y; Matsuoka Y; Suzuki H; Nishimura H; Terai H; Tamai K; Tagami A; Yamada S; Adachi S; Watanabe K; Katsumi K; Ohashi M; Shibuya Y; Harimaya K; Kawaguchi K; Yokoyama N; Oishi H; Doi T; Kimura A; Inoue H; Inoue G; Miyagi M; Saito W; Nakano A; Sakai D; Nukaga T; Ikegami S; Shimizu M; Futatsugi T; Ohtori S; Furuya T; Orita S; Imagama S; Ando K; Kobayashi K; Kiyasu K; Murakami H; Yoshioka K; Seki S; Hongo M; Kakutani K; Yurube T; Aoki Y; Oshima M; Takahata M; Iwata A; Endo H; Abe T; Tsukanishi T; Nakanishi K; Watanabe K; Hikata T; Suzuki S; Isogai N; Okada E; Funao H; Ueda S; Shiono Y; Nojiri K; Hosogane N; Ishii K
BMC Musculoskelet Disord; 2020 Jul; 21(1):420. PubMed ID: 32611386
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures.
Gourlay M; Franceschini N; Sheyn Y
Clin Rheumatol; 2007 Feb; 26(2):144-53. PubMed ID: 16670825
[TBL] [Abstract][Full Text] [Related]
8. Bone safety of low-dose glucocorticoids in rheumatic diseases.
Saag KG
Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
[TBL] [Abstract][Full Text] [Related]
9. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].
Heberlein I; Demary W; Bloching H; Braun J; Buttgereit F; Dreher R; Kuhn C; Lange U; Zink A; Zeidler H; Häntzschel H; Raspe H
Z Rheumatol; 2011 Sep; 70(7):592-601. PubMed ID: 21755301
[TBL] [Abstract][Full Text] [Related]
11. Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.
Nakamura Y; Suzuki T; Kato H
Arch Osteoporos; 2017 Sep; 12(1):80. PubMed ID: 28936606
[TBL] [Abstract][Full Text] [Related]
12. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
Wall E; Walker-Bone K
QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
[TBL] [Abstract][Full Text] [Related]
13. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
Moriwaki K; Fukuda H
Osteoporos Int; 2019 Feb; 30(2):299-310. PubMed ID: 30610244
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
Ma CC; Xu SQ; Gong X; Wu Y; Qi S; Liu W; Xu JH
Arch Osteoporos; 2017 Dec; 12(1):33. PubMed ID: 28374332
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A
Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109
[TBL] [Abstract][Full Text] [Related]
17. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-Induced Osteoporosis.
Buckley L; Humphrey MB
N Engl J Med; 2018 Dec; 379(26):2547-2556. PubMed ID: 30586507
[No Abstract] [Full Text] [Related]
19. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.
Feldstein AC; Elmer PJ; Nichols GA; Herson M
Osteoporos Int; 2005 Dec; 16(12):2168-74. PubMed ID: 16142501
[TBL] [Abstract][Full Text] [Related]
20. 2018 update of French recommendations on the management of postmenopausal osteoporosis.
Briot K; Roux C; Thomas T; Blain H; Buchon D; Chapurlat R; Debiais F; Feron JM; Gauvain JB; Guggenbuhl P; Legrand E; Lehr-Drylewicz AM; Lespessailles E; Tremollieres F; Weryha G; Cortet B
Joint Bone Spine; 2018 Oct; 85(5):519-530. PubMed ID: 29654947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]